Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Clinical Trial
    • About the Study
    • Am I Eligible?
  • Pipeline
    • Overview
    • Ampion
    • About Osteoarthritis
    • Optina
    • About Diabetic Macular Edema
  • Partnering
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 14, 2019

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.
Loading

Latest News

Ampio Starts Patient Enrollment in its Ampion COVID-19 Program

July 23, 2020

Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment of a New COVID-19 related Syndrome

July 20, 2020

Ampio to Start First Clinical Trial in COVID-19 Program

June 19, 2020
member-logo-85

© 2020 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Clinical Trial
  • Pipeline
  • Partnering
  • Investors
  • News
  • Contact Us